Literature DB >> 18188523

Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo.

Dorota Gabryś1, Annegret Dörfler, Ala Yaromina, Franziska Hessel, Mechthild Krause, Reinhard Oertel, Michael Baumann.   

Abstract

PURPOSE: To evaluate the effect of lovastatin alone or combined with radiation on U87MG and FaDu cells in vitro and U87MG tumors in vivo.
MATERIAL AND METHODS: Cell number, p21(WAF1) expression, apoptosis, reproductive cell death, and cell-cycle distribution were investigated after incubation of U87MG and FaDu cells in vitro. The effect of lovastatin (50 mg/kg/day) on tumor growth and on tumor growth delay after single-dose irradiation with 20 Gy was investigated using U87MG tumors in nude mice.
RESULTS: Lovastatin dose dependently decreased cell number and proliferation of U87MG and FaDu cells. The proportion of cells in G0/G1 phase, apoptosis and p21 protein expression increased after lovastatin alone or combined with 4-Gy irradiation in both cell lines. Effects of lovastatin on cell cycle and cell number were more pronounced in U87MG compared to FaDu. No radiosensitization of clonogenic cells by lovastatin could be demonstrated in both cells lines, but the colony-forming ability after lovastatin alone was decreased in FaDu cells. In vivo, lovastatin decreased tumor volume over time but did not increase growth delay after irradiation of U87MG tumors with 20 Gy.
CONCLUSION: The data support effects of lovastatin on proliferation, apoptosis and colony-forming ability in vitro and tumor volume in vivo. At the drug concentration achievable, lovastatin did not improve the effects of radiation on U87MG tumors in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188523     DOI: 10.1007/s00066-008-1805-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  17 in total

1.  Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines.

Authors:  Christina Eder-Czembirek; Boban M Erovic; Cornelia Czembirek; Markus Brunner; Edgar Selzer; Richard Pötter; Dietmar Thurnher
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

2.  In vitro Anti-Tumor Effects of Statins on Head and Neck Squamous Cell Carcinoma: A Systematic Review.

Authors:  Ludmila Madeira Cardoso Pavan; Daniela Fortunato Rêgo; Silvia Taveira Elias; Graziela De Luca Canto; Eliete Neves Silva Guerra
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

3.  Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.

Authors:  Frank Michael Klenke; Amir Abdollahi; Marc Bischof; Martha-Maria Gebhard; Volker Ewerbeck; Peter E Huber; Axel Sckell
Journal:  Strahlenther Onkol       Date:  2010-12-23       Impact factor: 3.621

Review 4.  The role of statins in neurosurgery.

Authors:  Jorge Humberto Tapia-Pérez; Martin Sanchez-Aguilar; Thomas Schneider
Journal:  Neurosurg Rev       Date:  2010-04-29       Impact factor: 3.042

Review 5.  Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.

Authors:  Dayle Rundle-Thiele; Richard Head; Leah Cosgrove; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

Review 6.  The effects of statins on dental and oral health: a review of preclinical and clinical studies.

Authors:  Shabnam Tahamtan; Farinaz Shirban; Mohammad Bagherniya; Thomas P Johnston; Amirhossein Sahebkar
Journal:  J Transl Med       Date:  2020-04-06       Impact factor: 5.531

7.  Omega-3 fatty acid supplementation in cancer therapy : does eicosapentanoic acid influence the radiosensitivity of tumor cells?

Authors:  Katrin Manda; Stephan Kriesen; Guido Hildebrandt; Rainer Fietkau; Gunther Klautke
Journal:  Strahlenther Onkol       Date:  2011-01-18       Impact factor: 3.621

8.  Cytotoxic effects of statins and thiazolidinediones on meningioma cells.

Authors:  Sonja Gehring; Jorge Humberto Tapia-Pérez; Elmar Kirches; Raimund Firsching; Gerburg Keilhoff; Thomas Schneider; Christian Mawrin
Journal:  J Neurooncol       Date:  2010-08-30       Impact factor: 4.130

9.  Gene expression signatures in the peripheral blood after radiosurgery of human cerebral arteriovenous malformations.

Authors:  Angelika Zabel-du Bois; Mechthild Wagner-Ecker; Stefanie Milker-Zabel; Christian Schwager; Ute Wirkner; Jürgen Debus; Amir Abdollahi; Peter E Huber
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

10.  The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cells.

Authors:  Cornelia Czembirek; Christina Eder-Czembirek; Boban M Erovic; Dritan Turhani; Andreas Spittler; Edgar Selzer; Richard Pötter; Dietmar Thurnher
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.